Testing effectiveness (Phase 2)UnknownNCT00003827What this trial is testingCombination Chemotherapy in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes ALZA 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976What this trial is testingAzacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaWho this might be right forChronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more National Cancer Institute (NCI) 282
Testing effectiveness (Phase 2)Study completedNCT00578942What this trial is testingAllo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using CampathWho this might be right forLymphomaMyelomaLeukemia+2 more David Rizzieri, MD 48
Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Very early researchUnknownNCT00434239What this trial is testingLenalidomide and Recombinant Human Stem Cell Factor for Treatment of MyelodysplasiaWho this might be right forMyelodysplasia Peter MacCallum Cancer Centre, Australia 25
Testing effectiveness (Phase 2)Study completedNCT00975975What this trial is testingBasiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more Indiana University 17
Testing effectiveness (Phase 2)Study completedNCT00352001What this trial is testingLenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Mikkael Sekeres MD 37
Not applicableStudy completedNCT05260203What this trial is testingMargheRITA (Remote Intelligence for Therapeutic Adherence)Who this might be right forMultiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more Advice Pharma Group srl 124
Early research (Phase 1)Ended earlyNCT00234000What this trial is testingAzacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT00004208What this trial is testingAntithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndromes Swiss Cancer Institute 86
Early research (Phase 1)Study completedNCT00015925What this trial is testingMS-275 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00795132What this trial is testingHematopoietic Cell Transplantation for Pediatric Patients With Hematologic MalignanciesWho this might be right forAcute LeukaemiaChronic DiseaseLeukemia+2 more University of Utah 47
Early research (Phase 1)Study completedNCT00004871What this trial is testingAzacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00006239What this trial is testingPhenylbutyrate and Tretinoin in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT07096297What this trial is testingLuspatercept + Darbepoetin in MDSWho this might be right forMDS (Myelodysplastic Syndrome) Yale University 60
Not applicableStudy completedNCT01807091What this trial is testingOutpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic SyndromeWho this might be right forAdult Acute Myeloid LeukemiaAdult Myelodysplastic Syndrome University of Washington 17
Testing effectiveness (Phase 2)Study completedNCT00580034What this trial is testingAllo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using CampathWho this might be right forLymphomaMyelomaLeukemia+2 more David Rizzieri, MD 176
Testing effectiveness (Phase 2)Study completedNCT00534430What this trial is testingBusulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic CancerWho this might be right forLeukemiaMyelodysplastic Syndromes City of Hope Medical Center 30